C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/12 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2749403
The compound of formula (1) or a salt, preferably a pharmaceutically acceptable salt, thereof; is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate mast cell activation, for instance allergic and inflammatory diseases, as well of potential use in cancer therapy, specifically heme malignancies.
La présente invention concerne le composé de formule (I) ou un sel, de préférence un sel pharmaceutiquement acceptable, de celui-ci; qui est un inhibiteur de la tyrosine kinase splénique (spleen tyrosine kinase : SYK) et qui peut être potentiellement utilisé pour traiter des maladies résultant d'une activation inappropriée des cellules mastocytes, par exemple des maladies allergiques et inflammatoires, mais également potentiellement utilisé dans une thérapie du cancer, en particulier des malignités héminiques.
Atkinson Francis Louis
Patel Vipulkumar Kantibhai
Glaxo Group Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Pyrimidinecarboxamide derivatives as inhibitors of syk kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinecarboxamide derivatives as inhibitors of syk kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinecarboxamide derivatives as inhibitors of syk kinase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1920164